Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01682434

Wavefront-guided LASIK for Correction of Myopia

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Aarhus University Hospital · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Laser in situ keratomileusis is a successful procedure for the treatment of low to moderate myopia. Advances over the last decade have allowed LASIK to also correct higher order wavefront aberrations. In low myopia, there seem to be a minor effect of such wavefront-guided treatment. However, it remains to be established whether there is a beneficial effect in higher degrees of myopia. The study aims to determine whether myopic subjects (-6 to -10 diopters) with higher-than-average preoperative higher-order aberrations have benefit of wavefront-guided treatment. Subjects are randomized to wavefront-guided treatment in one eye, and conventional treatment in the other.

Conditions

Interventions

TypeNameDescription
PROCEDURELaser in situ keratomileusis (LASIK)Wavefront guided treatment in one eye, conventional in the other.

Timeline

Start date
2011-05-01
Primary completion
2014-01-01
First posted
2012-09-11
Last updated
2014-05-02

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01682434. Inclusion in this directory is not an endorsement.